Vir Biotechnology
VIR
VIR
225 hedge funds and large institutions have $2.23B invested in Vir Biotechnology in 2023 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 87 increasing their positions, 72 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
225
Holders Change
-5
Holders Change %
-2.17%
% of All Funds
3.55%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
32
Increased
87
Reduced
72
Closed
34
Calls
$14.4M
Puts
$32M
Net Calls
-$17.6M
Net Calls Change
-$21.6M
Top Buyers
| 1 |
PA
1
Perceptive Advisors
New York
|
$48M |
| 2 |
PBA
2
Paradigm Biocapital Advisors
New York
|
$24.9M |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$25.1M |
| 4 |
4
Walleye Capital
New York
|
$21.2M |
| 5 |
OCA
5
Octagon Capital Advisors
New York
|
$15.9M |
